| Dr Kevin Michael Campbell, PHD | |
|
220 Montgomery St, Suite 1019, San Francisco, CA 94104-3402 | |
| (415) 505-6821 | |
| (509) 267-9371 |
| Full Name | Dr Kevin Michael Campbell |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 220 Montgomery St, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114944709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | PSY17864 (California) | Primary |
| 103TC0700X | Psychologist - Clinical | PSY17864 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Michael Campbell, PHD 220 Montgomery St, Suite 1019, San Francisco, CA 94104-3402 Ph: (415) 505-6821 | Dr Kevin Michael Campbell, PHD 220 Montgomery St, Suite 1019, San Francisco, CA 94104-3402 Ph: (415) 505-6821 |
News Archive
International biotechnology firm Cytonet recently launched the first ever clinical trial in the United States using an investigational liver cell infusion to treat urea cycle disorders (UCD) in children. The first patient in the Phase II trial, which will seek to enroll 20 patients in 12 medical centers, is a child with citrullinemia, which is a hereditary UCD. He received six liver cell infusions on six consecutive days at Yale School of Medicine in New Haven, Conn.
Prisons and partner organizations must do more to provide health and social care to growing population of older prisoners.
EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.
Among the countries that have successfully "flattened the curve" and managed to contain the coronavirus, is Australia. The country has managed to keep the viral transmission at bay and has now lifted some restrictions to let its residents return to more normal lives. Along with easing restrictions, the Australian Government launched the COVIDsafe app to help speed up contacting people infected with the virus.
The University of Pittsburgh Graduate School of Public Health and School of Medicine investigators will be leading a $15 million, five-year federal initiative to manage national clinical trials aimed at developing new treatments for breathing disorders.
› Verified 5 days ago
B L. Elliott, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 747 Front St, San Francisco, CA 94111 Phone: 707-508-6341 | |
Dr. David Tim Lewis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 Market St Ste 1208, San Francisco, CA 94103 Phone: 415-350-9611 | |
Candy Ho Katoa, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 401 Parnassus Ave, Lp 488, San Francisco, CA 94143 Phone: 415-476-7133 | |
Stephanie Lauren Post, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1630 Lombard St, San Francisco, CA 94123 Phone: 703-901-6833 | |
Anett Atman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3600 California St, San Francisco, CA 94118 Phone: 415-820-9612 | |
Dr. Andrea Samuels, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1947 Divisadero St Ste 1d, San Francisco, CA 94115 Phone: 510-847-4858 | |
Timothy Kim, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Scott St, San Francisco, CA 94115 Phone: 510-365-5066 |